These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9340173)

  • 21. PROGRESS (perindopril protection against recurrent stroke study): rationale and design. PROGRESS Management Committee [corrected].
    Neal B; MacMahon S
    J Hypertens; 1995 Dec; 13(12 Pt 2):1869-73. PubMed ID: 8903669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The management of blood pressure after stroke.
    Wityk RJ
    Neurologist; 2007 Jul; 13(4):171-81. PubMed ID: 17622908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
    Hansson L
    J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cerebrovascular sequelae of hypertension].
    Schrader J; Lüders S; Diener HC
    Herz; 2003 Dec; 28(8):707-16. PubMed ID: 14689105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood pressure reduction and risk of dementia in patients with stroke: rationale of the dementia assessment in PROGRESS (Perindopril Protection Against Recurrent Stroke Study). PROGRESS Management Committee.
    Tzourio C; Anderson C;
    J Hypertens Suppl; 2000 May; 18(1):S21-4. PubMed ID: 10939786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee.
    Chalmers J; Neal B; MacMahon S;
    J Hypertens Suppl; 2000 May; 18(1):S13-9. PubMed ID: 10939785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antihypertensive treatment preceding cerebrovascular diseases is insufficient according to recommendations].
    Nielsen AA; Christensen C; Brandslund I; Eriksen EW; Schmitz A
    Ugeskr Laeger; 2008 Oct; 170(41):3246-50. PubMed ID: 18940158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of high blood pressure in patients with acute apoplexy].
    Olsen TS; Jørgensen HS; Garde E; Lassen NA
    Ugeskr Laeger; 1995 Jun; 157(25):3623-5. PubMed ID: 7652982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hypotensive effect of 6-months cardiac rehabilitation in elderly patients].
    Kałka D; Sobieszczańska M; Marciniak W; Chorebała A; Markuszewski L; Metner E; Popielewicz-Kautz A; Korzeniowska J; Janczak J; Adamus J
    Pol Merkur Lekarski; 2007 Feb; 22(128):95-100. PubMed ID: 17598651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased vascular compliance/decreased cardiovascular risk: what the studies tell us.
    Frishman WH
    Heart Dis; 2000; 2(5):384-8. PubMed ID: 11728287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of arterial hypertension after ischemic cerebral stroke].
    Simonenko VB; Shirokov EA; Ovchinnikov IuV
    Klin Med (Mosk); 2006; 84(11):4-9. PubMed ID: 17243602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease.
    He J; Whelton PK
    J Hypertens Suppl; 1999 Jun; 17(2):S7-13. PubMed ID: 10465061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood pressure-lowering treatment for primary and secondary prevention of different types of stroke.
    Arima H
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):627-36. PubMed ID: 19505278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease.
    Campbell DJ; Woodward M; Chalmers JP; Colman SA; Jenkins AJ; Kemp BE; Neal BC; Patel A; MacMahon SW
    Arch Neurol; 2006 Jan; 63(1):60-5. PubMed ID: 16286536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary and secondary prevention of stroke by antihypertensive drug treatment.
    Wang JG; Li Y
    Expert Rev Neurother; 2004 Nov; 4(6):1023-31. PubMed ID: 15853529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An approach of patients with ischemic stroke to primary and secondary stroke prevention in Poland.
    Nowacki P; Porebska A; Bajer-Czajkowska A; Zywica A; Koziarska D; Podbielski J
    Ann Acad Med Stetin; 2007; 53(2):14-9. PubMed ID: 18557372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive treatment and stroke prevention: are angiotensin receptor blockers superior to other antihypertensive agents?
    Armario P; de la Sierra A
    Ther Adv Cardiovasc Dis; 2009 Jun; 3(3):197-204. PubMed ID: 19443514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aggressive blood pressure control and stroke prevention: role of calcium channel blockers.
    Papadopoulos DP; Papademetriou V
    J Hypertens; 2008 May; 26(5):844-52. PubMed ID: 18398322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.